These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10438848)

  • 1. An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency.
    Tan BT; Wu L; Berk AJ
    J Virol; 1999 Sep; 73(9):7582-9. PubMed ID: 10438848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
    Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
    J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication.
    Krougliak VA; Krougliak N; Eisensmith RC
    J Gene Med; 2001; 3(1):51-8. PubMed ID: 11269336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector.
    Gallaher SD; Gil JS; Dorigo O; Berk AJ
    J Virol; 2009 Apr; 83(7):3249-57. PubMed ID: 19158239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.
    Nasimuzzaman M; Kuroda M; Dohno S; Yamamoto T; Iwatsuki K; Matsuzaki S; Mohammad R; Kumita W; Mizuguchi H; Hayakawa T; Nakamura H; Taguchi T; Wakiguchi H; Imai S
    Mol Ther; 2005 Apr; 11(4):578-90. PubMed ID: 15771960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES; Tomkinson B; Kieff E
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent mice.
    Gil JS; Gallaher SD; Berk AJ
    Gene Ther; 2010 Oct; 17(10):1288-93. PubMed ID: 20463755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM; Wilkinson GW; Floettmann E; Blake N; Rickinson AB
    J Virol; 1996 Apr; 70(4):2394-402. PubMed ID: 8642667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus vectors for gene delivery to B lymphocytes.
    Robertson ES; Ooka T; Kieff ED
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11334-40. PubMed ID: 8876136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and properties of an Epstein-Barr-virus-derived cDNA expression vector for human cells.
    Belt PB; Groeneveld H; Teubel WJ; van de Putte P; Backendorf C
    Gene; 1989 Dec; 84(2):407-17. PubMed ID: 2482230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells.
    Yang L; Maruo S; Takada K
    J Virol; 2000 Nov; 74(22):10745-51. PubMed ID: 11044119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
    Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
    Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells.
    Rasmussen UB; Benchaibi M; Meyer V; Schlesinger Y; Schughart K
    Hum Gene Ther; 1999 Nov; 10(16):2587-99. PubMed ID: 10566887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
    Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
    J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.
    Sena-Esteves M; Saeki Y; Camp SM; Chiocca EA; Breakefield XO
    J Virol; 1999 Dec; 73(12):10426-39. PubMed ID: 10559361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation.
    Kieff E; Hennessy K; Fennewald S; Matsuo T; Dambaugh T; Heller M; Hummel M
    IARC Sci Publ; 1985; (60):323-39. PubMed ID: 2998995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.